Trials / Conditions / BCR-ABL1 Fusion Protein Expression
BCR-ABL1 Fusion Protein Expression
3 registered clinical trials studyying BCR-ABL1 Fusion Protein Expression — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Study of Efficacy and Safety of Flumatinib Combined With Chemotherapy in Ph Positive ALL NCT04375683 | Zhongda Hospital | Phase 3 |
| Recruiting | Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positi NCT03263572 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive NCT00390793 | M.D. Anderson Cancer Center | Phase 2 |